Status:
COMPLETED
Virtual Reality: Influence on Satisfaction, Pain, and Anxiety in Patients Undergoing Colposcopy
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Cervical Dysplasia
Pain
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Cervical cancer is one of the most common cancers in women and one of the leading causes of death in women worldwide. Pre-cancerous lesions (dysplasias) are detected by the screening smear test at the...
Detailed Description
HPV and cervical cancer Human papillomaviruses (HPV) are the most common sexually transmitted pathogens worldwide. The prevalence in the population is high. Epidemiological estimates suggest that 75-...
Eligibility Criteria
Inclusion
- Written consent to participate in the study
- Clinically indicated colposcopy in case of abnormal PAP smear for detection of precancerous lesions of the cervix uteri and/or clinical abnormality of the cervix uteri (e.g. leukoplakia) with biopsy
Exclusion
- Eye diseases (e.g., glaucoma/cataracts) that impair viewing of VR content.
- Claustrophobia/agoraphobia or epilepsy
- Patients with insufficient knowledge of the German language
Key Trial Info
Start Date :
May 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2022
Estimated Enrollment :
247 Patients enrolled
Trial Details
Trial ID
NCT04751799
Start Date
May 25 2021
End Date
July 10 2022
Last Update
April 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marien Hospital Herne
Herne, North Rhine-Westphalia, Germany, 44625